Carcinoma, Neuroendocrine
"Carcinoma, Neuroendocrine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)
MeSH Number(s)
C04.557.465.625.650.240
C04.557.470.200.025.370
C04.557.580.625.650.240
Concept/Terms
Carcinoma, Neuroendocrine- Carcinoma, Neuroendocrine
- Carcinomas, Neuroendocrine
- Neuroendocrine Carcinoma
- Neuroendocrine Carcinomas
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Neuroendocrine".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Neuroendocrine".
This graph shows the total number of publications written about "Carcinoma, Neuroendocrine" by people in Harvard Catalyst Profiles by year, and whether "Carcinoma, Neuroendocrine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2006 | 3 | 0 | 3 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 2 | 5 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 2 | 3 |
| 2011 | 3 | 7 | 10 |
| 2012 | 1 | 4 | 5 |
| 2013 | 3 | 5 | 8 |
| 2014 | 2 | 3 | 5 |
| 2015 | 6 | 3 | 9 |
| 2016 | 5 | 0 | 5 |
| 2017 | 3 | 3 | 6 |
| 2018 | 11 | 1 | 12 |
| 2019 | 18 | 0 | 18 |
| 2020 | 14 | 1 | 15 |
| 2021 | 19 | 0 | 19 |
| 2022 | 11 | 3 | 14 |
| 2023 | 1 | 0 | 1 |
Below are the most recent publications written about "Carcinoma, Neuroendocrine" by people in Profiles.
-
Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. Int J Mol Sci. 2023 Feb 13; 24(4).
-
IDH2 -Mutated Sinonasal Tumors: A Review. Adv Anat Pathol. 2023 Mar 01; 30(2):104-111.
-
The NOGO receptor NgR2, a novel aVß3 integrin effector, induces neuroendocrine differentiation in prostate cancer. Sci Rep. 2022 11 07; 12(1):18879.
-
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms. Oncologist. 2022 11 03; 27(11):940-951.
-
Follicular Neoplasm of Thyroid Revisited: Current Differential Diagnosis and the Impact of Molecular Testing. Adv Anat Pathol. 2023 Jan 01; 30(1):11-23.
-
Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine Neoplasia: A Report of 14 Cases. Am J Surg Pathol. 2022 12 01; 46(12):1670-1681.
-
Development and validation of an RNA sequencing-based classifier for medullary thyroid carcinoma on thyroid FNA. Cancer Cytopathol. 2023 03; 131(3):154-157.
-
LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer. Future Oncol. 2022 Sep; 18(28):3143-3150.
-
Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier. Thyroid. 2022 09; 32(9):1069-1076.
-
Diagnostic criteria and evolving molecular characterisation of pulmonary neuroendocrine carcinomas. Histopathology. 2022 Nov; 81(5):556-568.